By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Synthetic Genomics, Inc. 

11149 North Torrey Pines Road

La Jolla  California  92037  U.S.A.
Phone: 858-754-2900 Fax: 858-754-2988


Synthetic Genomics Inc. was founded to commercialize genomic-driven technologies. Our scientific strength lies in the decades of pioneering research by founders, J. Craig Venter, Ph.D., Nobel Laureate Hamilton O. Smith, M.D., and the leading scientific teams they have assembled. Dr. Venter and his teams have proven track records of making scientific breakthroughs that translate into viable commercial solutions.

The company's scientific capabilities encompass areas such as environmental genomics, microbiology, biochemistry, bioinformatics, plant genomics, genome engineering, synthetic biology, and climate change. In addition to the strong applied research efforts conducted at SGI, the company sponsors fundamental research at the J. Craig Venter Institute, a not-for-profit organization with more than 400 scientists and staff working on a variety of genomic research and policy fronts. In addition to the Intellectual Property developed internally, SGI has exclusive access to new inventions and discoveries in synthetic genomics research developed by the JCVI under the Sponsored Research Agreement between both organizations.

Key Statistics

Ownership: Private

Web Site: Synthetic Genomics


Start Up

Company News
Famed Genomics Pioneer's Synthetic Genomics Hit With Gender Discrimination Lawsuit by Former VP 9/21/2017 5:44:09 AM
Synthetic Genomics, Inc. Release: Bioxp Genomic Workstation Makes European Debut At VIB In Belgium 8/23/2017 6:12:40 AM
Synthetic Genomics, Inc. Launches cGMP Suite For Pharmaceutical Quality Manufacturing Of Synthetic DNA For Advaxis (ADXS)' Clinical Trials 6/1/2017 8:41:57 AM
Digital-To-Biological Converter For On-Demand Production Of Biologics Developed By Synthetic Genomics, Inc. 5/30/2017 8:28:29 AM
Synthetic Genomics, Inc., ExxonMobil Release: Companies Renew Algae Biofuels Research Agreement 1/18/2017 7:25:22 AM
Synthetic Genomics, Inc. Launches Vmax Express, A Next-Generation Protein Expression Platform For The Biotech Industry 1/9/2017 10:47:40 AM
Synthetic Genomics, Inc. Announces Collaboration With Johnson & Johnson Innovation (JNJ) To Develop Novel Therapeutics Using Synthetic Genomics' Replicon RNA Technology 1/5/2017 7:34:01 AM
Synthetic Genomics, Inc. Appoints Tina Nova, Ph.D., And William McKee To Board Of Directors 11/10/2016 4:18:01 PM
Synthetic Genomics, Inc. Team Engineers Vmax, An Advantaged Next-Generation Host Organism For A Wide Range Of Biotechnology Applications 8/29/2016 10:38:03 AM
Teams At Venter Institute And Synthetic Genomics, Inc. Successfully Engineer 16S rRNA Using One Step Process Combining CRISPR/Cas9 Systems And Yeast Recombination Machinery 8/4/2016 7:58:46 AM